Abstract
To test for replication of the association between variants in the CLU, CR1, and PICALM genes with Alzheimer disease. Follow-up case-control association study. The Mayo Clinics at Jacksonville, Florida, and Rochester, Minnesota. Community-based patients of European descent with late-onset Alzheimer disease (LOAD) and controls without dementia who were seen at the Mayo clinics, and autopsy-confirmed cases and controls whose pathology was evaluated at the Mayo Clinic in Jacksonville. Additional samples were obtained from the National Cell Repository for Alzheimer Disease (NCRAD). A total of 1829 LOAD cases and 2576 controls were analyzed. The most significant single-nucleotide polymorphisms in CLU (rs11136000), CR1 (rs3818361), and PICALM (rs3851179) were tested for allelic association with LOAD. Main Outcome Measure Clinical or pathology-confirmed diagnosis of LOAD. Odds ratios for CLU, CR1, and PICALM were 0.82, 1.15, and 0.80, respectively, comparable in direction and magnitude with those originally reported. P values were 8.6 x 10(-5), .014, and 1.3 x 10(-5), respectively; they remain significant even after Bonferroni correction for the 3 single-nucleotide polymorphisms tested. These results show near-perfect replication and provide the first additional evidence that CLU, CR1, and PICALM are associated with the risk of LOAD.
MeSH Terms
Alzheimer Disease/genetics,pathology
Case-Control Studies
Clusterin/genetics
Follow-Up Studies
Gene Frequency
Genetic Predisposition to Disease
Genome-Wide Association Study
Genotype
Humans
Monomeric Clathrin Assembly Proteins/genetics
Odds Ratio
Polymorphism, Single Nucleotide/genetics
Receptors, Complement 3b/genetics
Residence Characteristics
Whites
Chemicals
CLU protein, human
CR1 protein, human
Clusterin
Monomeric Clathrin Assembly Proteins
PICALM protein, human
Receptors, Complement 3b
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Carrasquillo Minerva M
Department of Neuroscience, Mayo Clinic, 4500 San Pablo Rd, Birdsall Building, Jacksonville, FL 32224, USA.
Belbin Olivia
Hunter Talisha A
Ma Li
Bisceglio Gina D
Zou Fanggeng
Crook Julia E
Pankratz V Shane
Dickson Dennis W
Graff-Radford Neill R
Petersen Ronald C
Morgan Kevin
Younkin Steven G
References (22)
22 references, click to expand
-
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6448-53
PMID: 9600986
-
The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family.
Proc Natl Acad Sci U S A. 1996 May 14;93(10):4804-9
PMID: 8643484
-
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
JAMA. 1997 Oct 22-29;278(16):1349-56
PMID: 9343467
-
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.
Nat Genet. 2009 Oct;41(10):1088-93
PMID: 19734902
-
Apolipoprotein J and Alzheimer's amyloid beta solubility.
Biochem J. 1996 Jun 1;316 ( Pt 2):671-9
PMID: 8687416
-
Role of genes and environments for explaining Alzheimer disease.
Arch Gen Psychiatry. 2006 Feb;63(2):168-74
PMID: 16461860
-
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.
Neurology. 1993 Aug;43(8):1467-72
PMID: 8350998
-
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.
Nat Genet. 2009 Oct;41(10):1094-9
PMID: 19734903
-
Genome-wide association studies in Alzheimer's disease.
Hum Mol Genet. 2009 Oct 15;18(R2):R137-45
PMID: 19808789
-
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
Science. 1993 Aug 13;261(5123):921-3
PMID: 8346443
-
Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.
Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4229-34
PMID: 8633046
-
Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic.
Mol Biol Cell. 1999 Aug;10(8):2687-702
PMID: 10436022
-
Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta.
Biochem Biophys Res Commun. 1994 Dec 15;205(2):1431-7
PMID: 7802679
-
Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.
Nat Genet. 2009 Feb;41(2):192-8
PMID: 19136949
-
Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease.
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10843-8
PMID: 12145324
-
The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.
Biochem J. 1993 Jul 1;293 ( Pt 1):27-30
PMID: 8328966
-
Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid.
Neurosci Lett. 1995 May 19;191(1-2):79-82
PMID: 7659297
-
Clusterin (Apo J) protects against in vitro amyloid-beta (1-40) neurotoxicity.
J Neurochem. 1996 Sep;67(3):1324-7
PMID: 8752142
-
The current status of Alzheimer's disease genetics: what do we tell the patients?
Pharmacol Res. 2004 Oct;50(4):385-96
PMID: 15304236
-
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
Neurology. 1984 Jul;34(7):939-44
PMID: 6610841
-
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.
Nat Genet. 2007 Feb;39(2):168-77
PMID: 17220890
-
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
Nat Genet. 2007 Jan;39(1):17-23
PMID: 17192785